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license (http://creativecommons.org/Summary Background/Objective: Plasma-sprayed titanium coating (TC) with rough surfaces
has been successfully applied in hip or knee prostheses. This study aimed to investigate the
osteoconduction and osseointegration of Type I collagen covalently immobilised on TC (TC-
AAC) compared with those of TC.
Methods: In vitro, the migration of human mesenchymal stem cells (hMSCs) on TC and TC-AAC
was observed by scanning electron microscopy and visualised fluorescent live/dead assay.
In vivo, a rabbit model with femur condyle defect was employed, and implants of TC and
TC-AAC were embedded into the femur condyles.
Results: Collagen immobilised on TC could promote hMSCs’ migration into the porous structure
of the TC. Micro computed tomography images showed that bone trabeculae were significantly
more abundant around TC-AAC implants than around TC implants. Fluorescence micrographs
indicated more active new-bone formation around implants in the TC-AAC group than in the
TC group. The measurement of boneeimplant contact on histological sections indicated signif-
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Plasma-sprayed titanium (Ti) coatings with rough surfaces
and macroporous structures have been widely and suc-
cessfully applied in orthopaedics, such as in hip replace-
ment and knee arthroplasty [1,2]. Bone tissue could grow
into the porous structures and form a mechanical interlock,
thereby providing a morphological fixation of implants
[3,4]. However, Ti is not osteoinductive, the early effect of
the implants remains unsatisfying, and improved osteoin-
tegration is required [5e7]. To improve osseointegration,
the further surface modification of Ti coatings is still one of
the most active research areas.
Compared with mechanical and physicochemical
methods, biochemical methodsdthe immobilisation of the
main components of the extracellular matrix, enzymes, or
peptides on a biomaterial surfacedhave attracted consid-
erable attention [8e11]. Type I collagen, themajor structural
protein in bone, has been most promising because of its well-
known role as mediator of osteoblastic cell functions,
including adhesion, differentiation, and extracellular-matrix
secretion [12,13]. Therefore, collagen has been used as
coating material on metal-based orthopaedic implants, such
as magnesium, stainless steel, and Ti [14e17]. Several stra-
tegies have been developed to immobilise Type I collagen
onto Ti surfaces, such as adsorptive immobilisation, covalent
binding from hydrocarbon plasma followed by acrylic acid
grafting, and the use of aminopropylsilane and 1-ethyl-3-
(3-dimethylaminopropyl)carbodiimide (EDC) [18e20]. In our
previous study, Type I collagen was immobilised onto plasma-
sprayed porous Ti coatings by either adsorptive or covalent
immobilisation [21]. The covalently immobilised collagen on
Ti coatings showed greater capability to regulate the osteo-
genic activity of humanmesenchymal stem cells (hMSCs) than
adsorbed collagen, butwhether thestemcells couldgrow into
the pores of the Ti coatings and the osteoconductivity of the
covalently immobilised collagen remained to be investigated.
Coating Ti surfaces with collagen stimulates bone for-
mation in vivo. Marra et al [20,22,23] found a significant in-
crease of boneeimplant contact (BIC) and bone ingrowth on
ColTi versus uncoated Ti fixtures in the early phases of
healing of the femur trabecular bone, femur cortical bone,
and tibia trabecular bone of rabbits. Mueller et al [24] and
Sverzut et al [25] also confirmed that Ti-based implant
coating with Type I collagen significantly influences peri-
implant bone regeneration. However, a significant aspect
not completely addressed in existing literature is the effect
of the osteoconduction and osseointegration of covalently
immobilised Type I collagen on porous Ti coatings in vivodin
other words, whether immobilised Type I collagen could
induce new bone and thereby fill the pores of Ti coating. The
present study tried to answer this question by providing somein vitro and in vivo results on the evaluation of Type I
collagen covalently immobilised on Ti coatings. Particularly,
the migration of hMSCs in vitro was observed with scanning
electron microscopy (SEM) and confocal laser scanning mi-
croscopy (CLSM). For in vivo study in rabbits, peri-implant
bone regeneration and the osseointegration of boneeim-
plant interfaces in femur were also investigated.
Materials and methods
Materials
Porous Ti coatings on Ti-6Al-4V substrates (TCs; F
10mm 2mmof plates andF 2.6mm 10mmof rods) were
fabricated by vacuum plasma spraying (F4-VB, Sulzer Metco,
Switzerland) as in previous literature [2]. Fine powder
(Shanghai, China) with an average size of 28.9 mmwas firstly
sprayed as a bond layer. Coarse powder with an average size
of 98.6 mmwas subsequently deposited on the bond layer to
form a porous structure with a porosity of approximately
30%. Type I collagen from calf skin was obtained from Sigma-
Aldrich (St. Louis, USA). Silane-coupling agent amino-
propyltriethoxysilane (APS), toluene, and N-hydrox-
ysuccinimide (NHS) were purchased from Shanghai
SinopharmChemical Reagent Corporation (Shanghai, China).
EDC was purchased from Tokyo Chemical Industry Company,
Ltd (Tokyo, Japan).
Preparation of type I collagen-modified Ti coatings
Type I collagen-modified TCs were prepared as previously
described [21]. The TC samples were treated in 5M NaOH at
80C for 12 hours and were then immersed in a boiling APS/
toluene solution (APS concentration of 10%) for silanisation.
After 12 hours, the APS-coated samples were ultrasonically
washed once in methanol and twice in deionised water and
then dried prior to further modification. Finally, the samples
were immersed in 1 mg/mL Type I collagen/acetic acid
(5mM) solution, which included 2.5mg/mL EDC and 0.63mg/
mL NHS, and were reacted for 6 hours. These Type I collagen
covalently immobilised TC samples were denoted as TC-AAC.
All samples were sterilised with g-ray irradiation.
In vitro study
Cell isolation and culture
hMSCs were isolated and expanded as previously described
[26]. Bone marrow aspirates were obtained from three
healthy donors (a 26-year-old man, 30-year-old woman, and
35-year-old man) during routine orthopaedic surgical pro-
cedures. The Ethical Committee of Shanghai Ninth People’s
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after being isolated from the bone marrow aspirates, cells
were cultured in an a-MEM culture medium supplemented
with 10% fetal bovine serum, 1% penicillin (100 U/mL), and
streptomycin sulphate (100 mg/mL) (Invitrogen, Carlsbad,
CA, USA), and incubated at 37C in a humidified atmosphere
of 5% CO2 and 95% air, with the growth medium changed
every 48 hours. hMSCs passaged up to the fourth generation
were used for the experiments described below.
Cell growth evaluation
Onemillilitre of the cell suspension at a cell density of 5 104
viable hMSCs was seeded into a 48-well plate containing two
kinds of samples (TC and TC-AAC), and then the mixtures
were incubated for 1 day or 5 days in a humidified 37C/5%
CO2 incubator. At each predetermined time point, hMSCs
were fixed overnight in 2% glutaraldehyde. After being rinsed
twice in PBS, the specimens were dehydrated in a graded
series of ethanol (30%, 50%, 70%, 80%, 95%, and 100%) and
ethanol/hexamethyldisilazane (HMDS) at various pro-
portions (2:1, 1:1, and 1:2 ethanol/HMDS and 100% HMDS).
The samples were then dried in an oven at 37C overnight.
The cells on the sample surface were investigated using SEM.
MTT assay was employed to determine the proliferation
of hMSCs on TC and TC-AAC. Briefly, the cells were incu-
bated with the specimens for 1 day or 5 days. At each
predetermined time point, 0.1 mL of the MTT solution was
added, and the specimens were incubated at 37C to form
formazan, which was then dissolved using 0.5 mL dime-
thylsulfoxide. Optical density was measured at 570 nm
using an automated plate reader (Synergy HT Multi-
detection Microplate Reader Shanghai, China).
The cytoskeleton of the hMSCs on the different samples
was analyzed using CLSM (A1R, Nikon, Japan). After 24 hours
of incubation with the two kinds of specimens described
earlier, the cells on the surfaces of the specimens were
washed gently with phosphate-buffered saline (PBS) three
times and then fixed with 4% paraformaldehyde for 15 mi-
nutes at room temperature. The cells were permeabilised
with 0.1% Triton X-100 (Shanghai, China) in PBS for 5 minutes
and then washed with PBS three times. The cells were
incubated with Alexa Fluor 555 phalloidin (Molecular Probes,
Sigma-Aldrich, St. Louis, USA) for 1 hour. After washing with
PBS again, the cell nuclei were stained with 40,60-diamidino-
2-phenylindole (Molecular Probes, Sigma-Aldrich, St. Louis,
USA). The cell morphologies were visualised using CLSM.
The viability and distribution of cells on the two kinds of
coatings after 1 day and 5 days of incubation were evaluated
using a live/dead assay kit (Abcam, Cambridge, England)
following the standard protocol provided by the manufac-
turer. Briefly, the cells and scaffold constructs were washed
twice with PBS and then incubated in standard working so-
lution at room temperature for 10 minutes. The constructs
were then washed twice with PBS and observed under CLSM
(A1R, Nikon, Japan).In vivo study
Surgical procedure
A rabbit model with femur condyle defect was used to
evaluate the in vivo function of collagen-modified TCs.Eighteen adult white New Zealand rabbits (male, 2e2.5 kg
body weight) obtained from the Laboratory Animal Center
of Shanghai Ninth People’s Hospital were divided into six
groups of three rabbits and six samples each. The use of
animals and the experimental protocol were approved by
the Institutional Animal Welfare Committee of Shanghai
Ninth People’s Hospital. The rabbits were anesthetised by
injecting 3% Nembutal (30 mg/kg) via the ear vein, and a
longitudinal incision was made by scalpel in the rabbit
femur under rigorous aseptic conditions. Circular holes
2.9 mm in diameter and 10 mm deep were drilled using a
surgical electronic drill and thoroughly rinsed with physio-
logical saline to remove shards of bone. Implants of TC and
TC-AAC were used in this study. The wound was sutured
with nylon thread. The rabbits were euthanized 1 month, 2
months, or 3 months after implantation.
Micro X-ray computed tomography analysis
After euthanasia, distal femurs with implants were
collected under aseptic conditions, fixed in 4% para-
formaldehyde for 2 days, and then rinsed with running
water for 24 hours. For the assessment of the bone archi-
tecture around the different implants after 3 months of
implantation, femur condyles with implants were examined
using a desktop micro X-ray computed tomography (micro-
CT; GE Locus SP, American) machine equipped with an 80 kV
X-ray source with a camera pixel size of 15 mm. During
scanning, the femur condyles were placed in polyethylene
tubes filled with 75 volume% alcohol. Micro-CT images along
the transection and midsagittal planes in the region around
the implant were obtained. The scans resulted in recon-
structed data sets with a voxel size of 28.79 mm. To
determine the trabecular volume of interest (VOI) in the
axial direction, the region of interest was chosen with its
closest edge at 4.0 mm distally from the growth plate. The
bone volume fraction (BV/TV), trabecular thickness
(Tb.Th), trabecular separation (Tb.Sp), and trabecular
number (Tb.N) were calculated as measurements of
trabecular bone mass and its distribution [27].
Fluorescence labelling of new-bone formation around
implants
To assess the osteogenic activity, the fluorochromic bone
marker calcein green (15 mg/kg; Sigma-Aldrich, St. Louis,
USA) was administered subcutaneously to all groups one
week prior to rabbit euthanasia. The specimens were
dehydrated through a series of graded ethanol solutions
(50%, 60%, 75%, 85%, 95%, and 100%). The dehydrated
specimens were preserved in absolute ethanol for subse-
quent assay and then embedded in polymethylmethacrylate
resin. Undecalcified sections with a thickness of 100 mm
were cut using a saw microtome (Leica ST1600, Heidelberg,
Germany). The thickness of the sections was polished to
50 mm using P300, P800, and P1200 abrasive paper and then
burnished with flannelette and abradum to 20e30 mm.
Finally, the fluorescence of calcein in bone tissues sur-
rounding the bone cement was visualised using CLSM (Leica
TCS SP2, Leica Microsystems, Heidelberg, Germany).
Measurement of BIC
Sections were prepared as described above. After being
dipped in 1% methane acid solution for 3 minutes and 20%
Titanium coated implants 19methanol solution for 2 hours, the sections were stained
with Van Gieson’s picrofuchsin and then observed
using fluorescence CLSM (Leica TCS SP5, Heidelberg,
Germany).
BIC was measured by image analysis software (Bioquant,
Nashville, American) according to previously reported
methods [28]. BIC levels were defined as the fraction of
direct bone apposition at the surface of the implant. The
total perimeter observed and the total perimeter attached
by bone were measured for each micrograph. Bone apposi-
tion was defined as a continuum ofmaterial from the surface
of the implant to the surrounding bone. The values were the
mean of the five samples.Statistical analysis
All assays of in vitro study were repeated three times. All
quantitative data were expressed as the mean  standard
deviation. Statistical differences were determined by an
analysis of variance. A p value < 0.05 was considered sta-
tistically significant.Figure 1 SEM images of growth and distribution of hMSCs on T
magnification in (AeD) and lower magnification in (E,F). hMSC Z
croscopy; TC Z titanium coating; TC-AAC Z type I collagen covaleResults
Cell growth evaluation
On the 1st day and 5th day after cell culture, the growth and
distribution of hMSCs on the surfaces of the two different
materials were observed by SEM, and the results are shown
in Figure 1. On Day 1, no obvious difference was observed
between the cells distributed on the surfaces of TC and TC-
AAC (Figures 1A and 1B). After cultivation for 5 days, many
cells can be found on the surface of TC, and the cells had
obviously proliferated compared with those at Day 1
(Figure 1C). By contrast, few cells were observed on the
surface of TC-AAC (Figure 1D), which were not only much
fewer than those on the surface of TC at Day 5 but also
fewer than those on the surface of TC-AAC at Day 1. The
same situation can be found within a larger scope (Figures
1E and 1F).
To investigate the proliferation of hMSCs on TC and TC-
AAC, MTT assay was employed. The results are shown in
Figure 2. On Day 5, the number of cells on TC-AAC wasC and TC-AAC after 1 day and 5 days of culture with higher
human mesenchymal stem cell; SEM Z scanning electron mi-
ntly immobilised on TC.
Figure 2 Proliferation of hMSCs on surfaces of TC and TC-
AAC. *p < 0.05 (comparison between different samples).
hMSCZ human mesenchymal stem cell; ODZ optical density;
TC Z titanium coating; TC-AAC Z type I collagen covalently
immobilised on TC.
Figure 3 Three dimensional confocal laser scanning micrograph o
incubation evaluated using live/dead assay kit. The live hMSCs wer
very few on all materials. hMSC Z human mesenchymal stem cell
immobilised on TC.
20 H.-Y. Ao et al.significantly greater than that on TC, indicating that the
proliferation of hMSCs on TC-AACwas better than that on TC.
The distribution of cells on the two kinds of coatings
after 1 day and 5 days of incubation was evaluated using a
live/dead assay kit. As shown in Figure 3, no yellow
staining was observed in the two groups, indicating that
the Ti, collagen, and hyaluronic acid all have excellent
cytocompatibility and noncytotoxicity. After 5 days of in-
cubation, the cell number of TC-AAC and TC was higher
than that after 1 day of incubation, and the number of
cells on TC-AAC after 5 days of incubation (Figure 3D) was
significantly higher than that on TC. On Day 1, the longi-
tudinal distribution of cells on both TC and TC-AAC was
about 295 mm. On Day 5, the longitudinal distribution of
cells on TC was about 305 mm, which had no significant
difference from that on Day 1. The longitudinal distribu-
tion of cells on TC-AAC was w400 mm, much deeper than
that of the other three groups. Furthermore, many cells
after 5 days of incubation attached onto the surface of TC,
while the majority of cells of TC-AAC were observed
deeper in the porosity. The results confirmed that hMSCsf hMSC distribution on TC and TC-AAC after 1 day and 5 days of
e stained green and the dead cells were stained red and were
; TC Z titanium coating; TC-AAC Z type I collagen covalently
Titanium coated implants 21migrated more easily into the porous structure of TC-AAC
than into that of TC.
The cytoskeleton of the hMSCs on the two different
samples was observed using CLSM (Figure 4). The hMSCs on
TC displayed spherical and fusiform morphology, while
those on TC-AAC exhibited polygonal and fusiform
morphology. The cytoskeleton of the hMSCs on TC-AAC
spread better than that on TC.
Micro-CT image analysis
Figure 5 shows themicro-CT images along the transection and
midsagittal planes in the region around the implants after 3
months of implantation. Trabecular bone around TC-AAC was
more abundant than that around TC. Table 1 lists the four
parameters of the trabecular VOI (4.0 mm) in the axial di-
rection. The BV/TV, Tb.Th, and Tb.N of TC-AAC were
7.45  0.23%, 0.066  0.002 mm, and 1.11  0.04 mm3,
respectively, all of which were significantly higher than those
of TC (6.10  0.22%, 0.062  0.001 mm, and
0.98  0.03 mm3; p < 0.05). The Tb.Sp of TC-AAC was
0.82  0.04 mm1, less than that of TC (0.95  0.04 mm1,
p < 0.05).
Fluorescence micrograph of new-bone formation
around implants
The bright-green fluorescence labelling of calcein in the
newly formed bone surrounding the two kinds of implants is
shown in Figure 6. As for TC, little green fluorescence was
detected around it after 1 month of implantation, indi-
cating that not much new bone had formed around theFigure 4 Cytoskeletal morphology and spreading of hMSCs on TC a
of cells stained with phalloidin for actin filaments (green) and nuc
hMSC Z human mesenchymal stem cell; TC Z titanium coating; Tsurface of TC. New bone around TC became more obvious
after 2 months of implantation, and this growth continued
to the end of the 3rd month after implantationdabout half
of the region surrounding TC was covered with green fluo-
rescence in both the 2nd month and 3rd month. By contrast,
much green fluorescence can be seen around TC-AAC after
1 month and 2 months of implantation. However, new bone
was almost not found in the 3rd month.
Histological observation and BIC
Figure 7A shows the histological appearance of implants
and bone after 1 month, 2 months, and 3 months of im-
plantation. The histological sections of implants and bone
after 1 month of implantation showed that only a small
number of trabeculae attached to the surfaces of the TC
implants. By contrast, much new bone can be found on the
TC-AAC surfaces and had close contact with the TC-AAC
implants. In the 2nd month, new bone was found on the
surface of TC. After 3 months of growth, new bone filled
the surfaces of the TC implants. Close observation showed
that new bone tissues had just grown along the periphery of
the porous structure and few of them had come into the
pores. Sometimes, new bone grew into the pores, but they
were very hard to fill. New bone was also found around TC-
AAC. Unlike those in TC, the vast majority of bone tissues
closely combined with TC-AAC.
The results of the BIC measurement are summarised in
Figure 7B. The value was 42.7  7.3% for the TC-AAC im-
plants after 1 month of implantation, significantly higher
than that for the TC implants (18.3  6.0%, p Z 0.00075).
Direct BIC increases with an increase in time ofnd TC-AAC after 24 hours of incubation. Representative images
lei counterstained with 40,60-diamidino-2-phenylindole (blue).
C-AAC Z type I collagen covalently immobilised on TC.
Figure 5 Micro-CT images along transection and midsagittal planes in region around implants after 3 months of implantation.
CT Z computed tomography; TC Z titanium coating; TC-AAC Z type I collagen covalently immobilised on TC.
22 H.-Y. Ao et al.implantation. After 3 months of implantation, the value for
the TC-AAC implants (60.1  9.8%) was also higher than that
for the TC implants (48.7  7.8%), although the difference
between them was not significant (p Z 0.011).
Discussion
Given their macroporous structures and high binding
strength with substrates, plasma-sprayed Ti coatings as
orthopaedic implants have attracted increasing attention.
Cell attachment, migration, proliferation, and differentia-
tion in the porous structure determine the suitability of
implants [29]. Both in vitro and in vivo studies confirm that
coating biomolecules, such as Type I collagen, on the sur-
face of Ti-based implants is one of the most effective
strategies to improve the bioactivity of Ti and accelerateTable 1 Microstructural parameters of trabecular volume of in
BV/TV (%) Tb.Th (mm)
TC 6.10  0.22 0.062  0.00
TC-AAC 7.45  0.23 0.066  0.00
Data are presented as mean  standard deviation.
BV/TV Z bone volume fraction; Tb.N Z trabecular number; Tb
TC Z titanium coating; TC-AAC Z type I collagen covalently immobiearly osteogenesis [30e33]. In our previous study, Type I
collagen was immobilised covalently on the surface of
plasma-sprayed porous Ti coatings, whose surfaces conse-
quently demonstrated improved hMSC attachment, prolif-
eration, and differentiation. In the present work, the
biological functions of collagen-modified Ti coatings were
further investigated in vitro and in vivo.
hMSCs have multidirectional differentiation potency and
play an important role in osseointegration [34]. The distri-
bution and proliferation of cells observed using SEM, MTT
assay, and three dimensional cell live/dead assay were
employed to investigate cell migration on the surfaces of TC
and TC-AAC. The number of cells on the surface of TC-AAC
after 5 days of cultivation was so low that it could not
reflect cell proliferation, which was demonstrated by MTT
assay (Figure 2). It was speculated that the cells hadterest in axial direction.
Tb.N (mm3) Tb.Sp (mm1)
1 0.98  0.03 0.95  0.04
2 1.11  0.04 0.82  0.04
.Sp Z trabecular separation; Tb.Th Z trabecular thickness;
lised on TC.
Figure 6 Confocal laser scanning micrograph showing green fluorescence labelling of calcein in newly formed bone around
implant in two groups. TC Z titanium coating; TC-AAC Z type I collagen covalently immobilised on TC.
Titanium coated implants 23migrated into the pores of TC-AAC, which was confirmed by
the results of three dimensional live/dead cell assay. The
results indicated that immobilised collagen could be helpful
to cell migration. Although showing good biocompatibility,
Ti is bioinert and thus affects cell migration [35]. Further-
more, the rough surface of Ti coating affects cell adhesion.
As shown in Figure 4, the hMSCs on TC displayed spherical
and fusiform morphology, and cells cannot closely attach to
TC, as shown in the SEM morphology of hMSCs cultured onFigure 7 (A) Histological morphology of interface between impla
implantation in rabbit femur condyles; (B) percentages of measur
*p > 0.05 (n Z 5). **p < 0.05 (n Z 5). TC Z titanium coating; TCthe specimens in our previous work [21]. The proliferated
cells with poor adhesive morphology mostly stay in the same
place and have difficulty migrating elsewhere, as shown in
Figure 1C. Type I collagen is considered the basic initial bone
matrix protein in bone formation [36]. It forms a scaffold for
the attachment and migration of hMSCs and modulates
various aspects of cell behaviour by mediating the flux of
chemical and mechanical stimuli [37]. With the help of
immobilised collagen, the hMSCs on TC-AAC displayednts and bone tissue after 1 month, 2 months, and 3 months of
ed boneeimplant contact of titanium coating-based implants.
-AAC Z type I collagen covalently immobilised on TC.
24 H.-Y. Ao et al.polygonal and fusiform morphology (Figure 4), and they
closely attached to TC-AAC. Excellent cell migration may be
helpful for osteoconduction and osseointegration.
To evaluate the osteoconduction and osseointegration of
collagen-immobilised Ti coatings, a rabbit model with
femur condyle defect was used. Both micro-CT scanning
and histological analysis were employed. The micro-CT
scans indicated that the osseointegration of TC-AAC im-
plants is better than that of TC implants after 3 months of
implantation. The fluorescent marker calcein was used to
label new-bone formation around the implants. Following
injection into the body, these active fluorescent markers
can bind with inorganic salt and then deposit into the
calcified bone matrix [38,39]. Therefore, new bone formed
after the injection of calcein is dyed green, which can
reflect the status of each stage of osseointegration. After 1
month of implantation, little green fluorescence is
observed around TC, while much green fluorescence is
observed around TC-AAC, indicating that at early stages,
the osseointegration of TC implants is poor and the osteo-
genic activity of TC-AAC is stronger than that of TC. Similar
results were obtained in the histological observation. More
bone tissues closely combined with TC-AAC than with TC,
and the BIC of TC-AAC implants was significantly higher
than that of TC implants, especially at the 1st month and
2nd month. Previous literature [20,24] has also confirmed
that covalently immobilised Type I collagen can improve
the BIC of Ti-based implants. This improvement may be
attributed to the bioinertness of Ti, which prevents osteo-
genesis [40]. Our previous in vitro experimental results [21]
demonstrated that the introduction of Type I collagen can
improve osteoblast differentiation, which may promote
bone formation. All results indicated that immobilised
collagen can improve the early osseointegration of TC-
based implants.
The early stabilisation of TC-based implants may be
improved by increased BIC. When bone tissue grows into
the pores, the mechanical interlock between implant and
bone may occur, and it may strengthen with more bone
embedded into the pores. Xue et al [40] confirmed by push-
out tests that alkali-modified Ti coating improves shear
strength and BIC. Push-out tests can enable the direct
measurement of the bonding strength between implant and
bone and will thus be performed in our future experiments.Conclusion
In this study, the osteoconduction and osseointegration of
Type I collagen covalently immobilised on Ti coatings were
investigated. The results of in vitro assay showed that
immobilised collagen can induce hMSCs’ migration into the
pores of Ti coating. Accordingly, in vivo study demonstrated
that immobilised collagen can improve the osteoconduction
and osseointegration of TC-based implants and may thus be
helpful to the early stabilisation of hip and knee prostheses
in orthopaedic clinics.Conflicts of interest
The authors declare no conflicts of interest in this work.Funding/support
This work was funded by the National Natural Science
Foundation of China (Nos. 51232007, 51172264, and
31200718), the Shanghai Science and Technology Develop-
ment Fund (13DZ2294000), and the Opening Project of the
Key Laboratory of Inorganic Coating Materials, Chinese
Academy of Sciences (KLICM-2014-04).References
[1] Xie Y, Liu X, Zheng X, Ding C. Bioconductivity of plasma
sprayed dicalcium silicate/titanium composite coatings on
Tie6Ale4V alloy. Surface Coatings Technol 2005;199:105e11.
[2] Shi J, Ding C, Wu Y. Biomimetic apatite layers on plasma-
sprayed titanium coatings after surface modification. Sur-
face Coatings Technol 2001;137:97e103.
[3] Jaeggi C, Mooser R, Frauchiger V, Wyss P. 3D characterization
of open porous vacuum plasma sprayed titanium coatings by
means of high resolution micro computer tomography. Mater
Lett 2009;63:2643e5.
[4] Chen Y, Zheng X, Ji H, Ding C. Effect of TieOH formation on
bioactivity of vacuum plasma sprayed titanium coating after
chemical treatment. Surface Coatings Technol 2007;202:
494e8.
[5] Treves C, Martinesi M, Stio M, Gutierrez A, Jimenez JA,
Lopez MF. In vitro biocompatibility evaluation of surface-
modified titanium alloys. J Biomed Mater Res Part A 2010;
92A:1623e34.
[6] Lin L, Wang H, Ni M, Rui Y, Cheng TY, Cheng CK, et al.
Enhanced osteointegration of medical titanium implant with
surface modifications in micro/nanoscale structures. J Orthop
Translation 2014;2:35e42.
[7] Yoon IK, Hwang JY, Jang WC, Kim HW, Shin US. Natural bone-
like biomimetic surface modification of titanium. Appl Surface
Sci 2014;301:401e9.
[8] Puleo DA, Nanci A. Understanding and controlling the bone-
eimplant interface. Biomaterials 1999;20:2311e21.
[9] Geißler U, Hempel U, Wolf C, Scharnweber D, Worch H,
Wenzel KW. Collagen type I-coating of Ti6Al4V promotes
adhesion of osteoblasts. J Biomed Mater Res 2000;51:752e60.
[10] Chen JL, Li QL, Chen JY, Chen C, Huang N. Improving blood-
compatibility of titanium by coating collageneheparin multi-
layers. Appl Surface Sci 2009;255:6894e900.
[11] Ao H, Xie Y, Qin A, Ji H, Yang S, Huang L, et al. Immobilization
of hyaluronic acid on plasma-sprayed porous titanium coatings
for improving biological properties. J Biomater Sci 2014;25:
1211e24.
[12] Mizuno M, Fujisawa R, Kuboki Y. Type I collagen-induced
osteoblastic differentiation of bone-marrow cells mediated
by collagen-a2b1 integrin interaction. J Cell Physiol 2000;184:
207e13.
[13] Maghdouri-White Y, Bowlin GL, Lemmon CA, Dre´au D. Mam-
mary epithelial cell adhesion, viability, and infiltration on
blended or coated silk fibroinecollagen type I electrospun
scaffolds. Mater Sci Eng: C 2014;43:37e44.
[14] Ma J, Thompson M, Zhao N, Zhu D. Similarities and differences
in coatings for magnesium-based stents and orthopaedic im-
plants. J Orthop Translation 2014;2:118e30.
[15] Mu¨ller R, Abke J, Schnell E, Macionczyk F, Gbureck U, Mehrl R,
et al. Surface engineering of stainless steel materials by co-
valent collagen immobilization to improve implant biocom-
patibility. Biomaterials 2005;26:6962e72.
[16] Uezono M, Takakuda K, Kikuchi M, Suzuki S, Moriyama K.
Hydroxyapatite/collagen nanocomposite-coated titanium rod
Titanium coated implants 25for achieving rapid osseointegration onto bone surface. J
Biomed Mater Res Part B: Appl Biomater 2013;101B:1031e8.
[17] Ao H, Xie Y, Tan H, Yang S, Li K, Wu X, et al. Fabrication and
in vitro evaluation of stable collagen/hyaluronic acid bio-
mimetic multilayer on titanium coatings. J Royal Soc Interface
2013;10:20130070.
[18] Becker D, Geißler U, Hempel U, Bierbaum S, Scharnweber D,
Worch H, et al. Proliferation and differentiation of rat cal-
varial osteoblasts on type I collagen-coated titanium alloy. J
Biomed Mater Res 2002;59:516e27.
[19] Mu¨ller R, Abke J, Schnell E, Scharnweber D, Kujat R, Englert C,
et al. Influence of surface pretreatment of titanium- and
cobalt-based biomaterials on covalent immobilization of
fibrillar collagen. Biomaterials 2006;27:4059e68.
[20] Morra M, Cassinelli C, Cascardo G, Cahalan P, Cahalan L,
Fini M, et al. Surface engineering of titanium by collagen
immobilization. Surface characterization and in vitro and
in vivo studies. Biomaterials 2003;24:4639e54.
[21] Ao H, Xie Y, Tan H, Wu X, Liu G, Qin A, et al. Improved hMSC
functions on titanium coatings by type I collagen immobili-
zation. J Biomed Mater Res Part A 2014;102:204e14.
[22] Morra M, Cassinelli C, Cascardo G, Mazzucco L, Borzini P,
Fini M, et al. Collagen I-coated titanium surfaces: mesen-
chymal cell adhesion and in vivo evaluation in trabecular bone
implants. J Biomed Mater Res Part A 2006;78A:449e58.
[23] Morra M, Cassinelli C, Cascardo G, Bollati D, Rodriguez y
Baena R. Multifunctional implant surfaces: surface charac-
terization and bone response to acid-etched Ti implants
surface-modified by fibrillar collagen I. J Biomed Mater Res
Part A 2010;94A:271e9.
[24] Mueller CK, Thorwarth M, Schmidt M, Schlegel KA, Schultze-
Mosgau S. Comparative analysis of osseointegration of tita-
nium implants with acid-etched surfaces and different bio-
molecular coatings. Oral Surg Oral Med Oral Pathol Oral Radiol
Endod 2011;112:726e36.
[25] Sverzut AT, Crippa GE, Morra M, de Oliveira PT, Beloti MM,
Rosa AL. Effects of type I collagen coating on titanium
osseointegration: histomorphometric, cellular and molecular
analyses. Biomed Mater 2012;7:035007.
[26] Tang TT, Lu H, Dai KR. Osteogenesis of freeze-dried cancellous
bone allograft loaded with autologous marrow-derived
mesenchymal cells. Mater Sci Eng C 2002;20:57e61.
[27] Qin L, Yao D, Zheng L, Liu WC, Liu Z, Lei M, et al. Phytomo-
lecule icaritin incorporated PLGA/TCP scaffold for steroid-
associated osteonecrosis: proof-of-concept for prevention of
hip joint collapse in bipedal emus and mechanistic study in
quadrupedal rabbits. Biomaterials 2015;59:125e43.
[28] Yu XW, Xie XH, Yu ZF, Tang TT. Augmentation of screw fixation
with injectable calcium sulfate bone cement inovariectomized rats. J Biomed Mater Res Part B: Appl Bio-
mater 2009;89B:36e44.
[29] Mohd Daud N, Sing NB, Yusop AH, Abdul Majid FA,
Hermawan H. Degradation and in vitro cellematerial inter-
action studies on hydroxyapatite-coated biodegradable
porous iron for hard tissue scaffolds. J Orthop Translation
2014;2:177e84.
[30] Scharnweber D, Born R, Flade K, Roessler S, Stoelzel M,
Worch H. Mineralization behaviour of collagen type I immo-
bilized on different substrates. Biomaterials 2004;25:
2371e80.
[31] Morra M, Cassinelli C, Cascardo G, Bollati D, Baena RRY.
Gene expression of markers of osteogenic differentiation of
human mesenchymal cells on collagen I-modified microrough
titanium surfaces. J Biomed Mater Res Part A 2011;96A:
449e55.
[32] Kung S, Devlin H, Fu E, Ho KY, Liang SY, Hsieh YD. The
osteoinductive effect of chitosan-collagen composites around
pure titanium implant surfaces in rats. J Periodontal Res 2011;
46:126e33.
[33] Korn P, Schulz MC, Hintze V, Range U, Mai R, Eckelt U, et al.
Chondroitin sulfate and sulfated hyaluronan-containing
collagen coatings of titanium implants influence peri-implant
bone formation in a minipig model. J Biomed Mater Res Part
A 2014;102:2334e44.
[34] Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R,
Mosca JD, et al. Multilineage potential of adult human
mesenchymal stem cells. Science 1999;284:143e7.
[35] Hu Y, Cai K, Luo Z, Zhang Y, Li L, Lai M, et al. Regulation of the
differentiation of mesenchymal stem cells in vitro and
osteogenesis in vivo by microenvironmental modification of
titanium alloy surfaces. Biomaterials 2012;33:3515e28.
[36] Christenson RH. Biochemical markers of bone metabolism: an
overview. Clin Biochem 1997;30:572e93.
[37] Bhatnagar RS, Qian JJ, Wedrychowska A, Sadeghi M, Wu YM,
Smith N. Design of biomimetic habitats for tissue engineering
with P-15, a synthetic peptide analogue of collagen. Tissue
Eng 1999;5:53e65.
[38] Ruhe´ PQ, Kroese-Deutman HC, Wolke JG, Spauwen PH,
Jansen JA. Bone inductive properties of rhBMP-2 loaded
porous calcium phosphate cement implants in cranial defects
in rabbits. Biomaterials 2004;25:2123e32.
[39] Tan H, Ao H, Ma R, Tang T. Quaternised chitosan-loaded
polymethylmethacrylate bone cement: biomechanical and
histological evaluations. J Orthop Translation 2013;1:
57e66.
[40] Xue W, Liu X, Zheng X, Ding C. In vivo evaluation of plasma-
sprayed titanium coating after alkali modification. Bio-
materials 2005;26:3029e37.
